EchoLaser TPLA at the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace (China)
Over 400 experts from 28 provinces attended the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace. We are proud that, for the third consecutive year, our Chinese partner, Chenglai Pharmaceutical, was among the key players at this prestigious event.
A highlight was the lecture by Dr. Paolo Polverino (San Giuseppe Hospital, Empoli – Italy), who presented:
“EchoLaser Transperineal Prostate Laser Ablation (TPLA): Technical Overview.”
His clinical expertise and focus on cutting-edge innovations generated great interest and brought valuable contributions to the scientific discussions.
A special thank you to Dr. Paolo Polverino for sharing his knowledge and to Chenglai Pharmaceutical for their outstanding organizational support.
EchoLaser TPLA continues to be recognized as a reference technology in minimally invasive prostate laser ablation, advancing laser surgery worldwide.
New Study Confirms EchoLaser as a Preferred and Safer Option for Thyroid Nodule Treatment
A prospective clinical study published in Scientific Reports highlights a growing patient preference for minimally invasive laser ablation over traditional surgical methods.
Led by Prof. Marcin Barczyński at the Thyroid Disease Treatment Center in Kraków, Poland, the study involved 204 patients with benign solitary thyroid nodules who were offered three treatment options: conventional surgery, TOETVA, or laser ablation (LA) using the EchoLaser system by Elesta.
Key results:
-
✅ 80% of patients opted for LA
-
📊 Technical success rate: 74.2%
-
📈 Clinical success rate: 90.2%
-
⚠️ Complication rate:
• LA: 1.8%
• TOETVA: 11.8%
• Open surgery: 8.7%
These findings confirm EchoLaser as a safe, effective, and patient-preferred treatment for benign thyroid nodules, offering excellent results with minimal risk.
We are proud of this recognition and thank Prof. Barczyński for this remarkable scientific contribution, and our distributor MEDEN for their partnership and ongoing support in Poland.
🔗 Read the full article here: https://doi.org/10.1038/s41598-025-10646-2
A New Milestone for EchoLaser and ModìLite: Supporting Clinical Excellence
We are proud to announce a new and significant achievement for our EchoLaser and ModìLite technologies: they have been selected by the Endocrine Surgery Unit at the Vanvitelli University Hospital in Naples, led by Professor Domenico Parmeggiani, for the treatment of thyroid disorders.
This important milestone once again confirms the clinical value of EchoLaser, renowned for its effectiveness, safety, and minimally invasive approach—features that continue to earn the trust of both medical professionals and patients.
Collaborating with centers of excellence such as the Vanvitelli University Hospital strengthens our mission: to provide cutting-edge therapeutic solutions that improve patients’ quality of life and support healthcare professionals with innovative and reliable technologies.
We extend our sincere thanks to the entire team at Vanvitelli University Hospital for their trust and collaboration.
EchoLaser International Collaboration: Prof. Abou-Taleb’s Clinical Tour in Italy
Over the past few days, we had the pleasure of welcoming Prof. Abou Taleb to Italy for a tour of top centers specializing in EchoLaser TPLA treatments.
📍 In Pisa, at Ospedale Cisanello, he met with Prof. Riccardo Bartoletti and Dr. Matteo Pacini.
https://lnkd.in/ddMg8PDN
📍 In Bergamo, at Clinica San Francesco – Casa di Cura Privata, he was hosted by Dr. Gianluigi Patelli and Dr. Vincenzo Altieri.
https://lnkd.in/dNrVnWfg
📍 Finally, in Florence, at Azienda Ospedaliero-Universitaria Careggi, he joined Dr. Francesco Sessa and Dr. Paolo Polverino, where he also received training on the UroFusion system from Esaote for targeted prostate biopsies and focal therapy.
https://lnkd.in/dMamC6c8
A heartfelt thank you to all the outstanding professionals involved for their warm welcome, expertise, and dedication. International clinical exchange is a key driver for advancing safe, effective, and innovative medical care. 🌍🤝
🙏 Special thanks also to Rocamed SAM, licensee of the EchoLaser technology, and to Mediclass, our distributor in Egypt, for their continued support in making this collaboration possible.